Staging of lymphoma under chimeric antigen receptor T-cell therapy: reasons for discordance among imaging response criteria.
Michael WinkelmannViktoria BlumenbergKai RejeskiVeit L BückleinMaria IngenerfMarcus UnterrainerChristian SchmidtFranziska J DekorsyPeter BartensteinJens RickeMichael von Bergwelt-BaildonMarion SubkleweWolfgang Gerhard KunzPublished in: Cancer imaging : the official publication of the International Cancer Imaging Society (2023)
Following CART, lymphoma response criteria show differences in imaging endpoints, especially in defining PD. The response criteria must be considered when interpreting imaging endpoints and outcomes from clinical trials.